Managed Detection & Response for MDC
Estimated value
£315k
Awarded value
£315k
Suppliers
1
Lots
1
Published
06 Apr 2022
Description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. The services provided will cover Endpoint Detection and Response Service, SIEM Threat Detection Service, MDR Retained Incident Response, Managed Network Intruder Alarm Service, and a DDI Guard software.
Scope
- Reference
- 0206-OPS
- Total value
- £315,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2022 to 30 Mar 2023
- CPV classifications
- 72000000
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Submission & procedure
- Submission deadline
- 28 Feb 2022, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£315k
Award date
01 Mar 2022
Contract start
31 Mar 2022
Contract end
30 Mar 2023